BioPharma Resources

Drug Trial Radar · NCT01897532

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk

Last checked: Nov 19, 2026Latest source record: Apr 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 6,991 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

6,991

Actual

Start

Jul 10, 2013

Primary completion

Jan 18, 2018

Study completion Jan 18, 2018

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
Collaborators
Eli Lilly and Company
First posted
Jul 12, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with Type 2 diabetes mellitus (T2DM) and to compare outcomes against placebo, on a background of standard of care.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • PlaceboDrug

    placebo matching tablets

  • LinagliptinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to the First Occurrence of Any of the Following Adjudication-confirmed Components of the Primary Composite Endpoint 3-point Major Adverse Cardiovascular (CV) Events (3-point MACE): CV Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke.Time frame: From randomization to individual end of observation; up to 4.3 years

Locations

649 sites in 27 countries. Site status is shown where the registry gives one.

  • Longwood Research

    Huntsville, Alabama

  • Scottsboro Quick Care Clinic

    Scottsboro, Alabama

  • Office of Dr. Terence T. Hart MD

    Tuscumbia, Alabama

  • Arrowhead Health Centers

    Glendale, Arizona

  • Precision Trials, LLC

    Phoenix, Arizona

  • Harrisburg Family Medical Center

    Harrisburg, Arkansas

  • Cardiology and Medicine Clinic

    Little Rock, Arkansas

  • Little Rock Diagnostic Clinic

    Little Rock, Arkansas

  • Kaiser Permanente - San Diego, Bonita

    Bonita, California

  • John Muir Physician Network Clinical Research Center

    Concord, California

  • Valley Research

    Fresno, California

  • VA Loma Linda Healthcare System

    Loma Linda, California

  • Long Beach Center for Clinical Research

    Long Beach, California

  • Clearview Medical Research, LLC

    Los Angeles, California

  • National Research Institute

    Los Angeles, California

  • Office of Dr. Richard S. Cherlin

    Los Gatos, California

  • Coastal Medical Research Group

    Los Osos, California

  • Novo Research, Incorporated

    Modesto, California

  • Providence Clinical Research

    North Hollywood, California

  • Northridge Clinical Research Inc.

    Northridge, California

  • Carr Cardiology

    Oceanside, California

  • Center for Clinical Trials of Sacramento, Incorporated

    Sacramento, California

  • North America Research Institute

    San Dimas, California

  • Trinitas Research, Incorporated

    San Jose, California

  • Metabolic Institute of America

    Tarzana, California

  • Center for Clinical Trials of San Gabriel

    West Covina, California

  • Western Nephrology & Metabolic

    Arvada, Colorado

  • South Denver Nephrology

    Denver, Colorado

  • Colorado Center for Bone Research, P.C.

    Golden, Colorado

  • Helix Biomedics LLC

    Boynton Beach, Florida

  • Orthopedic Research Institute

    Boynton Beach, Florida

  • Nova Clinical Research, LLC

    Bradenton, Florida

  • PAB Clinical Research

    Brandon, Florida

  • Meridien Research

    Brooksville, Florida

  • Southeast Clinical Research, LLC

    Chiefland, Florida

  • BayCare Medical Group

    Clearwater, Florida

  • Cohen Medical Research Associates, LLC

    Delray Beach, Florida

  • Innovation Medical Research Center, Inc

    Doral, Florida

  • Integrative Research Associates

    Fort Lauderdale, Florida

  • Jellinger and Lerman, MD, PA dba The Center for Diabetes and Endocrine Care

    Fort Lauderdale, Florida

Showing 40 of 649 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.